Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$15.30 USD
-0.38 (-2.42%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $15.32 +0.02 (0.13%) 4:52 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 36% (91 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.35 | 9.99 |
Current Quarter Estimate | -0.82 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -1.03 | 0.12 | 54.84 |
Next Quarter Estimate | -0.82 | 7.81 | 63.00 |
Next Year Estimate | -2.44 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 3.94 | 16.20 | 15.67 |
Next Year | 28.45 | 10.00 | 11.34 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 2.20 |
Price/Cash Flow (MRFY) | NA | 16.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -123.74% | -12.31% |
Return on Equity (TTM) | NA | -15.05% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.